欧洲药典适用性证书数据库
(Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM)
专论编号 物质名称 证书持有人 持有人ORG-ID和LOC-ID 证书编号 发布日期 证书状态 到期续期 证书结束日期 证书类型 上一程序的结束日期 历史数据
程序类型|结论|日期
2333 Fluvastatin sodium, Amorphous-2 BIOCON LIMITED Bengaluru IN 100011487;100018595 CEP 2022-139 - Rev 02 2025/09/22 Valid 22/07/2027 Chemical 2025/09/22 Minor revision|CEP granted|22/09/2025;
Administrative procedure|CEP granted|08/08/2022;
New application|CEP granted|22/07/2022
798 Fusidic acid, Process B FUJIAN COMHONY BIOTECHNOLOGY CO., LTD. Fuqing CN 100043888;100072481 CEP 2022-330 - Rev 02 2025/09/22 Valid 28/04/2028 Chemical 2025/09/22 Minor revision|CEP granted|22/09/2025;
Minor revision|CEP granted|15/10/2024;
New application|CEP granted|28/04/2023
848 Sodium fusidate, Process B FUJIAN COMHONY BIOTECHNOLOGY CO., LTD. Fuqing CN 100043888;100072481 CEP 2022-369 - Rev 02 2025/09/22 Valid 28/04/2028 Chemical 2025/09/22 Minor revision|CEP granted|22/09/2025;
Minor revision|CEP granted|04/11/2024;
New application|CEP granted|28/04/2023
2191 Atorvastatin calcium, Process 4, polymorphic form-I TAPI NL B.V. Amsterdam NL 100003852;100094134 CEP 2024-238 - Rev 02 2025/09/22 Valid 04/10/2029 Chemical 2025/09/22 Major revision|CEP granted|22/09/2025;
Notification|CEP granted|26/05/2025;
New application|CEP granted|07/10/2024
1472 Sodium hyaluronate, Intrinsic viscosity 1.55 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use AMHWA BIOPHARM CO., LTD. Binzhou CN 100054851;100097324 CEP 2018-285 - Rev 02 2025/09/19 Valid Chemical 2025/09/19 Renewal|CEP granted|19/09/2025;
Notification|CEP granted|21/06/2022
2737 Zolmitriptan MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN 100051463;100098142 CEP 2020-422 - Rev 03 2025/09/19 Valid 18/05/2027 Chemical 2025/09/19 Notification|CEP granted|19/09/2025;
Notification|CEP granted|15/07/2024;
Minor revision|CEP granted|13/10/2023;
Minor revision|Accepted - CEP remains valid|03/08/2023;
New application|CEP granted|18/05/2022
2465 Irbesartan, Process II MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN 100051463;100098142 CEP 2021-100 - Rev 04 2025/09/19 Valid 27/09/2026 Chemical 2025/09/19 Notification|CEP granted|19/09/2025;
Minor revision|Accepted - CEP remains valid|16/12/2024;
Notification|CEP granted|19/07/2024;
Minor revision|CEP granted|28/04/2023;
Minor revision|CEP granted|12/07/2022;
New application|CEP granted|27/09/2021
2585 Rizatriptan benzoate MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN 100051463;100098142 CEP 2011-299 - Rev 04 2025/09/19 Valid Chemical 2025/09/19 Notification|CEP granted|19/09/2025;
Notification|CEP granted|15/07/2024
2103 Propafenone hydrochloride MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN 100051463;100098142 CEP 2008-100 - Rev 05 2025/09/19 Valid Chemical 2025/09/19 Notification|CEP granted|19/09/2025;
Notification|CEP granted|11/07/2024;
Minor revision|Accepted - CEP remains valid|09/10/2020
1084 Cetirizine dihydrochloride MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN 100051463;100098142 CEP 2000-031 - Rev 13 2025/09/19 Valid Chemical 2025/09/19 Notification|CEP granted|19/09/2025;
Notification|CEP granted|19/07/2024;
Minor revision|Accepted - CEP remains valid|29/04/2024;
Minor revision|CEP granted|09/03/2022
2601 Pioglitazone hydrochloride MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN 100051463;100098142 CEP 2012-315 - Rev 02 2025/09/19 Valid Chemical 2025/09/19 Notification|CEP granted|19/09/2025;
Notification|CEP granted|11/07/2024;
Minor revision|Accepted - CEP remains valid|01/06/2021
2465 Irbesartan MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN 100051463;100098142 CEP 2010-124 - Rev 09 2025/09/19 Valid Chemical 2025/09/19 Notification|CEP granted|19/09/2025;
Minor revision|Accepted - CEP remains valid|19/12/2024;
Notification|CEP granted|19/07/2024;
Minor revision|CEP granted|26/04/2023;
Major revision|CEP granted|26/07/2022;
Major revision|CEP granted|10/06/2021
1756 Lamotrigine MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN 100051463;100098142 CEP 2009-157 - Rev 03 2025/09/19 Valid Chemical 2025/09/19 Notification|CEP granted|19/09/2025;
Notification|CEP granted|12/07/2024
931 Metformin Hydrochloride APITORIA PHARMA PRIVATE LIMITED Hyderabad IN 100049668;100086364 CEP 2004-088 - Rev 10 2025/09/18 Valid Chemical 2025/09/18 Minor revision|CEP granted|18/09/2025;
Minor revision|CEP granted|21/11/2024;
Notification|CEP granted|13/12/2023;
Minor revision|CEP granted|02/03/2021
2018 Paroxetine hydrochloride hemihydrate APITORIA PHARMA PRIVATE LIMITED Hyderabad IN 100049668;100086364 CEP 2006-206 - Rev 05 2025/09/18 Valid Chemical 2025/09/18 Minor revision|CEP granted|18/09/2025;
Minor revision|Accepted - CEP remains valid|15/10/2024;
Notification|CEP granted|13/12/2023;
Minor revision|CEP granted|26/01/2023;
Minor revision|Accepted - CEP remains valid|13/07/2022;
Notification|Accepted - CEP remains valid|06/11/2020
2617 Aripiprazole ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański PL 100000470;100001572 CEP 2013-230 - Rev 03 2025/09/18 Valid Chemical 2025/09/18 Minor revision|CEP granted|18/09/2025;
Minor revision|CEP granted|17/03/2023;
Monograph revision|CEP granted|16/07/2021;
Renewal|CEP granted|11/06/2020
334 Hydrocortisone acetate, Micronised, Grades I and II SYMBIOTEC PHARMALAB PRIVATE LIMITED Indore IN 100018972;100095999 CEP 2016-228 - Rev 03 2025/09/18 Valid Chemical 2025/09/18 Minor revision|CEP granted|18/09/2025;
Renewal|CEP granted|27/10/2023;
Minor revision|CEP granted|16/09/2022
1287 Alfuzosin hydrochloride APITORIA PHARMA PRIVATE LIMITED Hyderabad IN 100049668;100086364 CEP 2007-080 - Rev 04 2025/09/18 Valid Chemical 2025/09/18 Minor revision|CEP granted|18/09/2025;
Minor revision|Accepted - CEP remains valid|29/08/2024;
Notification|CEP granted|16/11/2023;
Notification|Accepted - CEP remains valid|15/07/2021;
Minor revision|Accepted - CEP remains valid|08/09/2020
2409 Diacerein AMI LIFESCIENCES PRIVATE LIMITED Vadodara IN 100021822;100030527 CEP 2015-173 - Rev 04 2025/09/18 Valid Chemical 2025/10/17 Minor revision|Accepted - CEP remains valid|17/10/2025;
Minor revision|CEP granted|18/09/2025;
Minor revision|CEP granted|03/12/2024;
Minor revision|Accepted - CEP remains valid|28/11/2022;
Administrative procedure|CEP granted|04/04/2022;
Notification|CEP granted|18/01/2022;
Renewal|CEP granted|17/11/2021
2751 Valaciclovir hydrochloride hydrate APITORIA PHARMA PRIVATE LIMITED Hyderabad IN 100049668;100086364 CEP 2013-318 - Rev 03 2025/09/18 Valid Chemical 2025/09/18 Minor revision|CEP granted|18/09/2025;
Notification|CEP granted|02/02/2024;
Major revision|CEP granted|22/08/2022

数据库说明:

当前数据更新日期:2026年02月10日。
©2006-2026 DrugFuture->Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM